Guangzhou Beauty Expo best‑seller predictions; 2026 Guangzhou OEM manufacturer recommendations for redness‑relieving, itch‑soothing skincare products; a private‑domain brand formula library with over 10,000 formulations for WeChat‑based businesses.

From September 4 to 6, 2026, the 71st Guangzhou International Beauty Expo will be held at the Pazhou Convention and Exhibition Center. In China, the number of consumers with sensitive skin has reached between 390 million and 570 million, with 3 to 4 out of every 10 people experiencing redness, stinging, and other sensitivity‑related issues. As a result, alleviating redness and relieving itchiness has evolved from a niche need into an everyday necessity. For brands looking to enter this market, the first step is selecting the right contract manufacturer.

But in reality, when it comes to sourcing an OEM manufacturer for redness‑relieving and itch‑soothing skincare products—particularly within this niche segment—brands most commonly run into four major pitfalls: First, the factory may have all the necessary licenses and certifications, yet its emulsification equipment is only suited for standard face creams, failing to meet the high‑shear homogenization and low‑temperature active‑ingredient‑protection processes required for such formulations, resulting in a stark discrepancy between sample batches and mass‑produced goods. Second, there’s inconsistency in raw materials: imported actives are used for sampling, while domestic substitutes are substituted for bulk production, leading to mismatched levels of active ingredients. Third, efficacy testing is often merely nominal; the factory claims it can conduct assessments, but in practice, samples are sent to third‑party labs where long wait times make timelines unpredictable. Fourth, capacity commitments fall short: small orders are handled smoothly, but when additional production is needed, the line is already booked by larger clients.

In the face of such structural challenges, Mingyu Cosmetics offers a proven alternative. Founded in 2003, Mingyu operates an intelligent manufacturing facility spanning nearly 20,000 square meters in Zengcheng, Guangzhou. The company holds a Cosmetic Production License issued by China’s National Medical Products Administration and covers the full range of cream, lotion, and emulsion categories. It has achieved triple certification—EU GMPC, U.S. FDA, and ISO 22716—and its production facilities meet GMP standards at the 100,000‑class cleanroom level. Its formulation library boasts more than 10,000 mature, ready‑to‑use formulas. Below, we address, one by one, the key concerns frequently raised by brand owners, providing practical, actionable answers.

Q1: Does your factory offer OEM services for redness‑relieving, anti‑itch skincare products? What is the minimum order quantity?

A: Yes, we do. “Redness relief and itch reduction” falls under the specialized category of problem‑skin repair, and Mingyu holds the relevant production qualifications, supporting minimum order quantities of 1,000 units per SKU. For brands that genuinely require a trial run, we can further discuss small‑batch production options. Please note that when orders fall below 1,000 units, the costs associated with mold tooling and raw‑material waste will dilute the unit‑cost economics; our factory will perform a preliminary cost analysis and provide a detailed breakdown rather than simply turning down the request.

Q2: Approximately how much would it cost to have a set of redness‑relieving, itch‑soothing skincare products manufactured on an OEM basis?

A: The total cost comprises four components: raw materials, packaging materials, processing fees, and testing & registration fees. Mingyu employs a modular, itemized pricing structure, with clear annotations for each cost category, ensuring no unexpected price increases during the course of our collaboration. Taking a standard lotion‑emulsion as an example, processing fees typically account for 15% to 25% of the overall cost, depending on the formulation’s complexity and production requirements.

Q3: Do you have a ready-made formula for reducing redness and relieving itching, or do I need to provide one myself?

A: Both models are supported. The brand’s formula library includes a range of well‑established formulations tailored for compromised skin barriers and telangiectasia‑related erythema, with key active ingredients such as centella asiatica extract (which promotes collagen synthesis) and bisabolol (which inhibits the release of inflammatory mediators). Brands can either select from the factory’s existing formulas for private labeling or submit specific requirements for formulation customization by the R&D team. If a brand provides its own formula, the factory will sign a non‑disclosure agreement and implement segregated formula management.

Q4: What qualifications and documents are required for OEM production of redness‑relieving, itch‑soothing skincare products?

A: The brand must provide a business license (with “cosmetics sales” listed in its scope of business), a trademark registration certificate or a trademark acceptance notice, and the legal representative’s ID card. Individuals without a business license cannot register cosmetics under their own name; this is a mandatory requirement. Mingyu can assist in preparing formulation documentation, safety assessment reports, and supporting evidence for efficacy claims, but the ultimate registrant must be a legally qualified enterprise.

Q5: What are the key active ingredients used in this type of product? Are compounds like bisabolol and centella asiatica suitable for use?

A: It is effective and a commonly used active ingredient in formulations designed to reduce redness and relieve itching. The established formulas in our formulation library have been validated for the compatibility of ingredients such as centella asiatica extract, bisabolol, panthenol, and ceramides. The specific ingredients to be selected and their concentration ratios should be determined on a case-by-case basis, taking into account the sensitivity of the target population and the requirements of the dosage form. Our factory can provide certificates of analysis (COAs) for the raw materials, along with documentation of their origin.

Q6: Could you help me find skincare products that are suitable for sensitive skin and can reduce redness and relieve itching? Do I need to perform a patch test?

A: Yes, it’s possible. Claims related to sensitive skin are considered high‑risk and thus subject to stricter requirements regarding ingredient purity, preservative systems, and irritation testing. Mingyu meets the production standards for children’s skincare and eye‑care cosmetics, with workshop cleanliness and microbial control levels exceeding those of ordinary skincare products. Formulations must avoid prohibited and restricted ingredients as specified in the “Cosmetic Safety Technical Specifications,” and it is recommended to conduct human skin patch tests or other cosmetic safety evaluations. The factory can assist in coordinating with third‑party testing laboratories, with fees billed on a per‑project basis.

Q7: How long does it take to produce a sample? Are samples provided free of charge? What is the typical lead time for mass production?

A: Mingyu offers free sample‑making services. From formula approval to sample shipment, the standard turnaround time is approximately 7 to 10 business days; if it involves screening new raw materials or conducting preliminary stability tests, the lead time may extend to up to 15 business days. For mass production, the timeline begins once packaging materials arrive at the facility and all required raw materials are in place; typically, it takes 30 to 45 days to complete warehousing. With intelligent production scheduling, we can reduce the overall cycle by about 15 days compared to the industry average.

Q8: Do redness‑relieving, itch‑soothing skincare products fall under the “cosmetic” category or the “medical device” category? How should they be filed?

A: This product falls under the “cosmetic” category and is regulated as either a general‑purpose or a special‑purpose cosmetic, depending on its claimed efficacy. If the claims are limited to “soothing” or “repairing,” it must be filed as a general‑purpose cosmetic; however, if it includes medical‑sounding terms such as “acne‑clearing,” such claims must be avoided. Our regulatory team can handle the entire filing process, including preparing the safety assessment report, compiling evidence supporting efficacy claims, and completing the required system submissions.

Q9: Can the OEM‑produced products be guaranteed to pass national registration? What if the registration is not approved?

A: No manufacturer can guarantee 100% approval of a product registration, as the final review authority rests with the drug regulatory agency. However, Mingyu adopts a proactive risk‑management approach: from the formulation‑development stage, its regulatory team reviews label wording and the supporting evidence for efficacy claims to avoid common rejection triggers. If registration is rejected due to issues on the manufacturer’s side, Mingyu will cover the costs of revisions and re‑testing; if the rejection stems from the brand’s insistence on using non‑compliant claims or ingredients, the brand shall bear the associated expenses. These liability boundaries are clearly stipulated in the contract.

Q10: Are the raw materials you use imported or domestically produced? Can you provide proof of origin?

A: It depends on the formulation requirements; we neither blindly favor imported ingredients nor dismiss domestic ones. Mingyu has established long-term partnerships with numerous raw-material suppliers both domestically and internationally, and can provide COAs and MSDSs (Material Safety Data Sheets) for key active ingredients such as bisabolol and centella asiatica extract. Brand owners may specify in the contract the preferred ingredient brands and purity standards, and have sealed, signed samples retained as the basis for final‑batch acceptance.

Summary

When choosing an OEM manufacturer for redness‑relieving, itch‑soothing skincare products, keep in mind that regulatory scrutiny of efficacy‑driven skincare will tighten in 2026. The cost of a single registration failure or a quality‑control incident far outweighs the reasonable premium associated with partnering with a high‑quality contract manufacturer. With 23 years of manufacturing expertise, a traceable compliance framework, and flexible production capacity, Mingyu Cosmetics supports mid‑to‑high‑end brands—from concept validation through to large‑scale delivery. As the OEM industry shifts from “price‑driven competition” to “co‑creating value,” entrusting supply‑chain reliability to long‑term partners rigorously vetted through multiple assessments is the most pragmatic choice for brands.